Navigation Links
Gene Therapy Shows Early Promise for Heart Failure
Date:2/21/2013

By Amy Norton
HealthDay Reporter

THURSDAY, Feb. 21 (HealthDay News) -- When it comes to treating heart failure, the ultimate hope is to develop a therapy that repairs the damaged heart muscle.

Now, an early study hints at a way to do that by harnessing the body's natural capacity for repair.

Heart failure is a chronic, progressive condition where the heart cannot pump blood efficiently enough to meet the body's needs, which leads to problems like fatigue, breathlessness and swelling in the legs and feet. Most often, it arises after a heart attack leaves heart muscle damaged and scarred.

In the new study, researchers were able to use gene therapy to modestly improve symptoms in 17 patients with stage III heart failure -- where the disease is advanced enough that even routine daily tasks become difficult.

What is novel about the tactic, the researchers said, is that the gene therapy is designed to attract the body's own stem cells to the part of the heart muscle that's damaged. The hope is that the stem cells will then get some repair work done.

The findings, published Feb. 21 in the journal Circulation Research, are preliminary, and much more research needs to be done.

"This is a proof-of-concept study," explained lead researcher Dr. Marc Penn, a professor at Northeast Ohio Medical University in Rootstown, and director of research at Summa Cardiovascular Institute in Akron. But Penn and other heart failure experts said they were cautiously optimistic about the therapy's potential for at least some patients.

Stem cells are primitive cells that can develop into different types of body tissue. Adults have the cells in their bone marrow, and they give rise to blood cells. Researchers have also found that individual organs in the body, including the heart, have their own pools of stem cells.

Those stem cells may try to repair damaged tissue, but they are not all that successful, Pe
'/>"/>

Copyright©2012 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3 4

Related medicine news :

1. Sniffing out the side effects of radiotherapy may soon be possible
2. Study shows long-term efficacy of minimally invasive therapy for patients with Barretts esophagus
3. BUSM authors propose potential epigenetic mechanisms for improved cancer therapy
4. Zippy Rolling Ball Therapy Hosting Vendor Table at AZ Roller Derby Event on Saturday, Feb 23, 2013
5. Discovery in HIV may solve efficiency problems for gene therapy
6. Study: Behavioral therapy for children with autism can impact brain function
7. Hopkins scientists create method to personalize chemotherapy drug selection
8. Cancer Chemotherapy Tied to Slight Rise in Risk for Leukemia
9. Risk of leukemia after cancer chemotherapy persists
10. Copper depletion therapy keeps high-risk triple-negative breast cancer at bay
11. Could Duration of Prostate Cancer Hormone Therapy Be Halved?
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Gene Therapy Shows Early Promise for Heart Failure
(Date:11/28/2014)... Brosix is always making changes to its infrastructure architecture ... efficient, effective, and secure experience. Most recently, the company ... ability to setup local servers for each country or ... around the globe. , 2. The ability to setup ... require millions of users in one network. , 3. ...
(Date:11/28/2014)... New York, NY (PRWEB) November 28, 2014 ... Auto Salvage ( http://www.rustysautosalvage.com ), one of the nation's ... used, junk and salvage vehicles to be more competitive ... their customer’s lives during this festive time of year. ... friends, many car owners across the US also deal ...
(Date:11/28/2014)... (PRWEB) November 28, 2014 Junk-A-Car ( ... is expanding their service offerings to help drivers, especially ... Philadelphia and Washington, D.C. metropolitan areas deal with the ... across a large part of the country. , With ... resulting in hundreds of totaled, crashed and junk ...
(Date:11/28/2014)... 2014 Dr. Diane Walder, one of ... the addition of Dr. Bridgit Nolan to her practice ... after having completed her dermatology residency at the University ... invited Dr. Nolan to join her practice ... cosmetic dermatology. Not only does Dr. Nolan strive to ...
(Date:11/28/2014)... (PRWEB) November 28, 2014 Novatus, ... announced its Release v5.1 which provides customers with ... workflow options. , “As we continue to ... to provide more functionality and improved performance in ... Gambotz, CEO for Novatus. “With the enhancements that ...
Breaking Medicine News(10 mins):Health News:Brosix Infrastructure Architecture Changes to Benefit Users 2Health News:Rusty's Auto Salvage Increasing Their Cash Offers to Help Drivers Save Throughout the Busy Holiday Season 2Health News:Junk-A-Car Expanding Service to Assist U.S. Car Owners That May be Affected by Severe Winter Storms 2Health News:Dr. Diane Walder Welcomes New Cosmetic Dermatologist to Practice 2Health News:Novatus Releases v5.1 with New Advanced Reporting Capabilities 2
... Following its recent,merger with Echo Therapeutics, Inc., ... platform-enabled transdermal specialty,therapeutics and diagnostics company, today announced ... Therapeutics, Inc., effective Monday, October 8,2007. In addition, ... Board,ticker symbol will change to "ECTE" and its ...
... ON, Oct. 5 /PRNewswire-FirstCall/ - Bioniche Life Sciences,Inc., a research-based, technology-driven Canadian biopharmaceutical,company (TSX:BNC), will be ... cattle vaccine,during a: ... ... ...
... 5 Sundance Catalog is proud to,support Susan G. ... end breast,cancer forever by empowering people, ensuring quality care ... of the retail sales price of,the Cherokee "Health" Tee ... a guaranteed minimum donation of $5,000.00. The Cherokee word,for ...
... Edward G. Rendell,today joined the Pennsylvania Dental Association (PDA) ... recognizing October 5, 2007,as Senior Smiles Day in Pennsylvania. ... individual,s overall,health and quality of life," Rendell said in ... adults over the age of sixty-five reside,in the commonwealth ...
... In a significant advancement in the ongoing battle against ... IC-MedTech and other institutions have completed the first ever ... Apatone exploits a new strategy to selectively lower the ... energy production and protect against chemotherapy. This non-toxic ...
... 5 Florida drivers won a major,victory today ... no-fault auto insurance law. The reformed law, which ... both chambers with,overwhelming support. The new changes in ... The Coalition particularly applauded Senator Bill Posey ...
Cached Medicine News:Health News:Sontra Medical Corporation Changes Name to Echo Therapeutics, Inc. 2Health News:Cherokee 'Health' Tee Proceeds Benefit Breast Cancer Research 2Health News:Governor Rendell Declares Senior Smiles Day in Pennsylvania; Goal is to Improve Oral Hygiene for Senior Citizens 2Health News:Researchers complete first clinical trial of Apatone for cancer treatment 2Health News:Researchers complete first clinical trial of Apatone for cancer treatment 3Health News:Hospitals and the Coalition to Protect Florida's Drivers Applaud Lawmakers for Reviving No-Fault Insurance 2
(Date:11/26/2014)... Colo. , Nov. 25, 2014   Heska Corporation ... "Heska" or the "Company"), a provider of advanced veterinary ... Robert Grieve , Executive Chair, will attend The Benchmark ... 2014. The one-on-one conference will be held at The Palmer ... from 8 a.m. to 2:30 p.m. Please email ...
(Date:11/26/2014)... BOULDER, Colo. , Nov. 25, 2014 ... ARRY ) today announced that its Chief ... speak at the following upcoming conferences.  The ... conferences through webcasts on the Array BioPharma ... ConferenceDate:Wednesday, December 3, 2014Time:1:30 p.m.  Eastern Time ...
(Date:11/26/2014)... LONDON , Nov. 25, 2014 Amgen (NASDAQ: ... ) today announced that AMAGINE-2 TM , a pivotal, multi-arm ... than 1,800 patients with moderate-to-severe plaque psoriasis, met its primary ... placebo at week 12. Brodalumab 210 mg given every two ... to be superior to Stelara on the primary endpoint of ...
Breaking Medicine Technology:Heska to Attend Benchmark Micro Cap Discovery Conference 2Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 2Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 3Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 4Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 5Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 6Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 7Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 8Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 9Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 10
... (Nasdaq: OMCL ), a leading provider of system ... quarter and year ended December 31, 2010. ... was $57.3 million, up $1.0 million or 1.7% from the ... from the fourth quarter of 2009.  Revenue for the year ...
... Thoratec Corporation (Nasdaq: THOR ), a world ... support and restore failing hearts, said today that revenues ... over those in fiscal 2009. Results from ... quarter of fiscal 2010 and 2009 exclude contributions from ...
Cached Medicine Technology:Omnicell Announces Fourth Quarter and Full Year 2010 Results 2Omnicell Announces Fourth Quarter and Full Year 2010 Results 3Omnicell Announces Fourth Quarter and Full Year 2010 Results 4Omnicell Announces Fourth Quarter and Full Year 2010 Results 5Omnicell Announces Fourth Quarter and Full Year 2010 Results 6Omnicell Announces Fourth Quarter and Full Year 2010 Results 7Omnicell Announces Fourth Quarter and Full Year 2010 Results 8Omnicell Announces Fourth Quarter and Full Year 2010 Results 9Omnicell Announces Fourth Quarter and Full Year 2010 Results 10Omnicell Announces Fourth Quarter and Full Year 2010 Results 11Omnicell Announces Fourth Quarter and Full Year 2010 Results 12Thoratec Reports 37 Percent Increase in Annual Revenues From Continuing Operations 2Thoratec Reports 37 Percent Increase in Annual Revenues From Continuing Operations 3Thoratec Reports 37 Percent Increase in Annual Revenues From Continuing Operations 4Thoratec Reports 37 Percent Increase in Annual Revenues From Continuing Operations 5Thoratec Reports 37 Percent Increase in Annual Revenues From Continuing Operations 6Thoratec Reports 37 Percent Increase in Annual Revenues From Continuing Operations 7Thoratec Reports 37 Percent Increase in Annual Revenues From Continuing Operations 8Thoratec Reports 37 Percent Increase in Annual Revenues From Continuing Operations 9Thoratec Reports 37 Percent Increase in Annual Revenues From Continuing Operations 10Thoratec Reports 37 Percent Increase in Annual Revenues From Continuing Operations 11Thoratec Reports 37 Percent Increase in Annual Revenues From Continuing Operations 12Thoratec Reports 37 Percent Increase in Annual Revenues From Continuing Operations 13Thoratec Reports 37 Percent Increase in Annual Revenues From Continuing Operations 14Thoratec Reports 37 Percent Increase in Annual Revenues From Continuing Operations 15
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: